Skip to main content

Table 1 Patient characteristics

From: Patency period of a metallic ureteral stent and its determinants in patients with malignant ureteral obstruction: a prospective review

Case

Sex

Age

PS

Location

Diagnosis

Compression by solid mass

Peritoneal metastasis

Height (cm)

Stent length (cm)

Stricture position

Stricture length (cm)

 

1

F

65

0

Right

Ovarian cancer

 

158

24

L

2

 

2

M

48

0

Right

Rectal cancer

 

172

26

M

3

 

3

F

83

0

Left

Colon cancer

 

151

24

U-L

16

 

4

F

70

2

Bilateral

Gastric cancer

 

149

22/24*

U-L/U-L*

16/16*

 

5

F

81

1

Bilateral

Ovarian cancer

 

152

24/28*

L/U*

3/2*

 

6

M

66

0

Left

Rectal cancer

 

168

22

L

2

 

7

F

75

1

Right

Gastric cancer

 

153

22

U-L

11

 

8

F

61

1

Right

Uterine cancer

 

161

26

L

3

 

9

M

79

1

Right

Caecal cancer

 

156

22

L

1

 

10

M

60

0

Left

Colon cancer

 

152

24

M

2

 

11

F

64

1

Bilateral

Lung cancer

 

154

24/24*

U/U*

3/3*

 

12

F

81

1

Left

Rectal cancer

 

166

26

M

2

 

13

F

70

0

Left

Breast cancer

 

158

24

U

4

 

14

F

68

2

Bilateral

Pancreatic cancer

 

151

22/20*

U/M*

1/1*

 

15

M

64

1

Left

Gastric cancer

 

165

24

M

4

 

16

F

87

2

Left

Pancreatic cancer

 

153

24

U

16

 

17

F

82

1

Bilateral

Peritoneal cancer

 

155

22/22*

U/U*

3/5*

 

18

F

90

1

Right

Duodenal cancer

 

145

24

L

3

 

19

M

86

0

Right

Colon cancer

 

167

22

U

5

 

20

F

65

0

Bilateral

Gastric cancer

 

155

22/26*

L/U*

3/3*

 

21

F

73

0

Left

Rectal cancer

 

158

22

U

7

 
  1. PS performance status, solid mass: tumour and lymph node dissemination, *Right/Left, U upper ureter, M middle ureter, L lower ureter, UL from upper ureter to lower ureter